John J. Maroney, is presently the President, CEO and Director of Juvent, Inc., a company focused on the development of a medical device that provides patients with a unique, non-invasive, and low-cost alternative to the conventional pharmaceutical therapies currently used in the treatment of osteoporosis, osteopenia, and related conditions. From 1992 to 2002 he was President, CEO, Co-Founder and Chairman of Flemington Pharmaceutical Corporation located Flemington, New Jersey (now NovaDel Pharmaceuticals). NovaDel is a publicly-held (AMEX: NVD) drug development company engaged in the development of novel application drug delivery systems for presently marketed prescription, OTC,and veterinary rugs utilizing its patented lingual spray delivery system.


From 1983 to Present he was President of Landmark Financial Corporation located in Spring Lake , New Jersey . Landmark is a provider of corporate finance services to emerging growth companies in the healthcare sector, specializing in merger and acquisition and product licensing work. Landmark was an affiliate of New York-based investment banking firm Ladenburg, Thalmann from 1984 - 1991, during which time Mr. Moroney held the position of Managing Director. Mr. Maroney graduated from Fordham University with a B.S. in 1975 and received his MBA in 1977 from Fordham University .

View the personal profiles and accomplishments of Infinity Capital.


Management

Gregory H. Laborde | Chairman & CEO

Theodore A. Greenberg | Chief Investment Officer, CFO, Director

Steven Katz | SR VP Business Development, Director


Disinterested Directors

Pierce McNally, Director

Conrad Huss, Director

Ernest D. Chu, Director

John Maroney, Director